Filters
reset allOther countries
Results: 1 to 13 of 13
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
FLVCR2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Proliferative Vasculopathy and Hydranencephaly-Hydrocephaly Syndrome via the FLVCR2 Gene PreventionGenetics United States | 1 | 1 |
|
PreventionGenetics United States | 40 | 37 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Arthrogryposis panel. NGS panel of 69 genes. Genologica Medica Spain | 135 | 69 |
|
Neuronal migration disorder panel. NGS panel of 58 genes. Genologica Medica Spain | 110 | 57 |
|
Hydrocephalus (NGS Panel and Copy Number Analysis) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 5 | 172 |
|
CeGaT GmbH Germany | 1 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Results: 1 to 13 of 13
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.